# PLGLB1

## Overview
PLGLB1 is a gene that encodes the protein plasminogen-like B1, which is involved in the process of fibrinolysis, the breakdown of fibrin in blood clots. This protein is categorized as an extracellular matrix protein and shares functional similarities with plasminogen, a precursor to the enzyme plasmin, which plays a critical role in tissue remodeling and wound healing (Cortese2008DNA; Bao2019Differential). The expression of PLGLB1 is primarily regulated by DNA methylation patterns, particularly in the liver, and it exhibits high sequence homology with other members of the PLG gene family (Cortese2008DNA). Additionally, PLGLB1 has been identified as having antiangiogenic properties, which may influence vascular health by inhibiting endothelial cell proliferation and blood tube formation (Wu2022Longitudinal). The gene's expression and function have been implicated in various clinical contexts, including as a potential biomarker for SARS-CoV-2 infection and in the regulation of the HIV reservoir (Dwivedi2023Differences; Wu2022Longitudinal).

## Function
PLGLB1, or plasminogen-like B1, encodes a protein involved in fibrinolysis, the process of breaking down fibrin in blood clots. This protein is similar to plasminogen, a precursor to plasmin, which is an enzyme that degrades fibrin, suggesting a role in tissue remodeling and wound healing (Cortese2008DNA). The PLGLB1 protein is active in the extracellular matrix, where it may participate in processes involving plasminogen, such as fibrinolysis and tissue remodeling (Bao2019Differential).

In healthy human cells, PLGLB1 is expressed in the liver, where its expression is regulated by DNA methylation patterns. The gene shows high sequence homology to other members of the PLG gene family, which includes PLG, PLGLA, and PLGLB2, and shares similar methylation-dependent expression patterns (Cortese2008DNA). The methylation status of PLGLB1 is inversely correlated with its expression, indicating a conserved regulatory mechanism across the PLG gene family (Cortese2008DNA).

PLGLB1 also exhibits antiangiogenic properties, inhibiting endothelial cell proliferation and blood tube formation, which may influence vascular health and repair (Wu2022Longitudinal). This function suggests a potential role in maintaining vascular integrity and preventing excessive angiogenesis.

## Clinical Significance
PLGLB1 has been identified as a potential biomarker for SARS-CoV-2 infection, with its expression levels significantly elevated in COVID-19 patients across all severity groups, including asymptomatic individuals. The protein's high stability allows it to differentiate COVID-19 patients from uninfected individuals with high sensitivity and specificity, as demonstrated by a receiver operating characteristic curve analysis showing an area under the curve of 0.99, with a sensitivity of 98% and specificity of 100% (Wu2022Longitudinal). The study suggests that PLGLB1's antiangiogenesis function, which involves inhibiting endothelial cell proliferation and blood tube formation, may hinder the rehabilitation of blood vessels damaged by SARS-CoV-2 infection, potentially contributing to the long-term effects of COVID-19 (Wu2022Longitudinal).

In the context of HIV, PLGLB1 has been associated with higher levels of HIV intact DNA, which estimates the replication-competent HIV reservoir. This association was observed in individuals of European ancestry, suggesting that PLGLB1 might play a role in the size of the HIV reservoir and could contribute to vascular and metabolic complications in HIV-positive individuals undergoing antiretroviral therapy (Dwivedi2023Differences). These findings highlight the need for further research to validate the role of PLGLB1 in these conditions.


## References


[1. (Cortese2008DNA) Rene Cortese, Manuel Krispin, Gunter Weiss, Kurt Berlin, and Florian Eckhardt. Dna methylation profiling of pseudogene–parental gene pairs and two gene families. Genomics, 91(6):492–502, June 2008. URL: http://dx.doi.org/10.1016/j.ygeno.2008.02.004, doi:10.1016/j.ygeno.2008.02.004. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2008.02.004)

2. (Dwivedi2023Differences) Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection. This article has 2 citations.

[3. (Wu2022Longitudinal) Songfeng Wu, Yuan Xu, Jian Zhang, Xiaoju Ran, Xue Jia, Jing Wang, Longqin Sun, Huan Yang, Yulei Li, Bin Fu, Changwu Huang, Pu Liao, and Wei Sun. Longitudinal serum proteome characterization of covid-19 patients with different severities revealed potential therapeutic strategies. Frontiers in Immunology, July 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.893943, doi:10.3389/fimmu.2022.893943. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.893943)

[4. (Bao2019Differential) Minwei Bao and Gening Jiang. Differential expression and functional analysis of lung cancer gene expression datasets: a systems biology perspective. Oncology Letters, May 2019. URL: http://dx.doi.org/10.3892/ol.2019.10362, doi:10.3892/ol.2019.10362. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2019.10362)